Prognostic analysis. (A) Event-free survival, censored at the stem-cell transplantation time (P = .04 by log-rank test); after adjustment for trial and age, the P value for the TLX1-high versus TLX1-low/-neg comparison was .035. (B) Overall survival, censored at stem-cell transplantation time (P = .08 by log-rank test); after adjustment for trial and age, the P value for the TLX1-high versus TLX1-low/-neg comparison was .059.